All Access Pass - 1 FREE Month!
Institutional email required, no credit card necessary.

Myasthenia Gravis for USMLE Step 1 & COMLEX-USA Level 1

FREE ONE-MONTH ACCESS
Institutional (.edu or .org) Email Required
Register Now!
No institutional email? Start your 1-week free trial, now!
Pathophysiology
    • Autoimmune disorder where antibodies (primarily IgG) target acetylcholine receptors at the neuromuscular junction.
    • Results in impaired neuromuscular transmission, leading to muscle weakness.
Genetics and Immunology
    • HLA Association: Linked to HLA-DR3.
    • Thymus involvement: Thymic hyperplasia or thymoma present in many patients, indicating a role in pathogenesis.
Clinical Features
    • Ocular Symptoms: Ptosis and diplopia are common initial manifestations.
    • Generalized Muscle Weakness: Affects facial, bulbar, and limb muscles; worsens with exertion, improves with rest.
    • Respiratory Complications: Risk of myasthenic crisis, a life-threatening exacerbation leading to respiratory failure.
Diagnosis
    • Serology: Detection of anti-acetylcholine receptor (AChR) antibodies; anti-MuSK antibodies may be present in AChR-negative cases.
    • Electrophysiological Testing: Repetitive nerve stimulation shows decremental response; single-fiber electromyography (EMG) is highly sensitive.
    • Pharmacologic Test: Edrophonium (Tensilon) test historically used, though less commonly now.
Treatment
    • Acetylcholinesterase Inhibitors: Pyridostigmine to increase acetylcholine availability at the neuromuscular junction.
    • Immunosuppressive Therapy: Corticosteroids, azathioprine, or other agents for long-term control.
    • Plasmapheresis/IVIG: Used in acute management or before surgery.
    • Thymectomy: Indicated in patients with thymoma and considered in generalized disease.
Pathological Findings
    • Muscle Biopsy: Typically normal; however, may show small type II fiber atrophy in chronic cases.
    • Thymus Histology: Thymic hyperplasia or thymoma in many cases.
Commonly Tested Items on Step 1
    • Autoantibodies: Anti-AChR and anti-MuSK.
    • Clinical presentation: Ocular symptoms and generalized weakness that improves with rest.
    • Thymus association: Role of thymic abnormalities in pathogenesis.
    • Edrophonium test: Historical importance in diagnosis.
    • Management principles: Acetylcholinesterase inhibitors and the role of thymectomy.